AVNT vs TECH · P/E 32, rev $3.24B vs P/E 65, rev $1.22B
Avient Corp (AVNT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Avient Corp (AVNT) is a specialty chemicals company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AVNT revenue for 2024-12-31 was $3.24B. Net income was $170.7M. Revenue was up 3.1% from 2023-12-31 to 2024-12-31. AVNT currently screens at market cap $3.13B and trailing P/E 31.7.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AVNT currently screens at market cap $3.13B and trailing P/E 31.7. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AVNT and TECH stock pages for the full models.
Not investment advice.